Prescription drug · ANDA
Reltone 200 mg (Ursodiol) NDC 80056-143
Ursodiol 200 mg/1 · Capsule · Oral · Intra-Sana Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 80056-143-01 | 80056014301 | 100 CAPSULE in 1 BOTTLE (80056-143-01)Marketed from Feb 15, 2021 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Reltone 200 mg
- Generic name (nonproprietary)
- ursodiol
- Active ingredients
- Ursodiol — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Intra-Sana LaboratoriesNDC labeler code 80056
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 205789
- Marketing start
- Listing expires
- Other FDA classes
- Bile Acids and Salts (Chemical structure)
- Identifiers
- Product ID 80056-143_1fc18c67-20db-4fe5-bc22-2772f0788d13SPL ID 1fc18c67-20db-4fe5-bc22-2772f0788d13SPL set ID d1c28b0b-8f3c-4d60-8182-24a4c659d762RxCUI 412174, 2376942, 2477896, 2477898UNII 724L30Y2QRUPC 0380056144010, 0380056143013
- Pharmacologic class
- Bile Acid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N480056014301followed by a unit qualifier and the quantityPackage 80056-0143-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE 1. Reltone™ is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of Reltone™ beyond 24 months is not established. 2. Reltone™ is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.
Excerpt only. Read the full label for complete information.
About NDC 80056-143
- What is NDC 80056-143?
- 80056-143 is the product NDC for Reltone 200 mg (ursodiol), Ursodiol 200 mg/1 capsule, listed with the FDA by Intra-Sana Laboratories. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Reltone 200 mg (Ursodiol).
- What is the active ingredient?
- Ursodiol.
- Who is the labeler?
- Intra-Sana Laboratories, NDC labeler code 80056. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Reltone 200 mg?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under ANDA 205789
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Reltone 400 mgursodiol | Ursodiol 400 mg/1 | CapsuleOral | Intra-Sana Laboratories | 80056-144 |
| Ursodiol 200 mgursodiol | Ursodiol 200 mg/1 | CapsuleOral | FH2 Pharma LLC | 72887-143 |
| Ursodiol 200 mgusodiol | Ursodiol 200 mg/1 | CapsuleOral | LGM PHARMA SOLUTIONS, LLC | 79739-7143 |
| Ursodiol 400 mgursodiol | Ursodiol 400 mg/1 | CapsuleOral | FH2 Pharma LLC | 72887-144 |
| Ursodiol 400 mgusodiol | Ursodiol 400 mg/1 | CapsuleOral | LGM PHARMA SOLUTIONS, LLC | 79739-7144 |